跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 31,616 条关于
“severe alopecia areata”
全部
31,616
临床试验
23,989
药物
282
机构
92
资讯
7,253
去年
Sun Pharma Launches Deuruxolitinib for Severe Alopecia Areata in US Market
去年
Pfizer's Litfulo Becomes First NHS-Approved Treatment for Severe Alopecia Areata
去年
Topical Immunotherapy Shows Promise for Severe Alopecia Areata Despite Variable Response Rates
去年
FDA Approval of Leqselvi Marks Major Advancement in Severe Alopecia Areata Treatment
昨天
FDA Approves Lilly's Olumiant for Adolescents 12 and Older With Severe Alopecia Areata
去年
Hengrui Pharmaceutical Secures NMPA Approval for JAK1 Inhibitor Ivarmacitinib in Severe Alopecia Areata
2年前
FDA Approves Leqselvi (Deuruxolitinib) for Severe Alopecia Areata
9个月前
Almirall Advances LAD603 from Phase 1 Completion to Phase 2 Trial for Severe Alopecia Areata
去年
Baricitinib Shows Promising Hair Regrowth Results in Adolescents with Severe Alopecia Areata in Phase 3 Trial
去年
FDA Approves Baricitinib as First Systemic Treatment for Severe Alopecia Areata Based on Phase 3 Trial Results
第 1 页,共 726 页
上一页
下一页